Cargando…
Innovative Strategies in Tissue Engineering.
In spite of intensive investments and investigations carried out in the last decade, many aspects of the stem cell physiology, technology and regulation remain to be fully defined. After the enthusiasm that characterized the first decade of the discovery that when given the right cue, stem cells cou...
| Clasificación: | Libro Electrónico |
|---|---|
| Autor principal: | |
| Otros Autores: | |
| Formato: | Electrónico eBook |
| Idioma: | Inglés |
| Publicado: |
Aalborg :
River Publishers,
2015.
|
| Colección: | River Publishers series in research and business chronicles: biotechnology and medicine.
|
| Temas: | |
| Acceso en línea: | Texto completo |
Tabla de Contenidos:
- Cover; Half Title; Title; Copyright; Contents; Preface; List of Figures; List of Abbreviations; 1. Bioactive Nanocomposites withApplications in Biomedicine; Abstract; 1.1 Introduction; 1.2 Factors that Influence the Quality of a Biomaterial; 1.3 Layered Silicate Nanocomposites for Biomaterials; 1.3.1 Layered Silicate Properties; 1.3.2 Layered Silicate Purification; 1.3.3 Layered Silicate in Drug Release Systems; 1.3.4 Biopolymers Properties; 1.4 Routes for Obtaining Bio-Nanocomposites; 1.5 Biomaterials Development; 1.6 Conclusions; References.
- 2. Cerium Dioxide Nanoparticles ProtectCardiac Progenitor Cells against theOxidative StressAbstract; 2.1 Interaction of Cerium Oxide Nanoparticleswith Biological Systems; 2.2 Cerium Oxide Nanoparticles Shield Cardiac PrecursorCells against the Oxidative Stress; References; 3. Animals Models and In Vitro Alternativesin Regenerative Medicine: Focus onBiomaterials Development; 3.1 Introduction; 3.1.1 Animals in Medical Research; 3.1.2 Ethical Considerations of Animal Use; 3.2 Designing Animal Experiments; 3.2.1 Randomization and Blinding; 3.2.2 Control Groups; 3.2.3 Statistical Analysis.
- 3.2.4 Design Stages3.3 Limitations of Animal Models; 3.3.1 Animal Species; 3.3.2 Health and Age Status; 3.3.3 Reproducibility; 3.4 Examples of Animal Models for Cardiac and CornealRegenerative Medicine Testing; 3.4.1 Myocardial Infarct and Other Ischemic Models; 3.4.1.1 Myocardial coronary artery ligation; 3.4.1.3 Hind-limb ischemia; 3.4.1.2 Cryoinjury; 3.4.2 Corneal Transplantation Models; 3.4.2.1 Animal species; 3.4.2.2 Lamellar and penetrating keratoplasty; 3.4.2.3 Infectious models; 3.5 In Vitro Systems as Alternatives to Animal Testing.
- 3.5.1 In Vitro Corneal Equivalents for Screening Biomaterialsas Potential Implants3.5.2 In Vitro Angiogenesis Models; 3.6 Conclusion; References; 4. Differentiation Plasticity of GermlineCell-Derived Pluripotent Stem Cells andTheir Potential Application in RegenerativeMedic; Abstract; 4.1 Introduction; 4.2 Hepatocytes Derived from GPSCs; 4.3 Cardiac Cells Derived from GPSCs; 4.4 Neuronal Cells Derived from GPSCs; 4.5 Hematopoietic Cells from GPSCs; 4.6 Vascular Cells Derived from GPSCs; References; 5. Mechanical Stimulation in TissueEngineering; 5.1 Background and Introduction.
- 5.1.1 Mechanical Theories of Material Damage5.1.2 Damage of Living Tissue; 5.2 Mechanical Loading in Two Dimensions; 5.2.1 Hertz-inspired Tissue Deformation; 5.2.2 Preliminary Results of Cell Straining; 5.3 Conclusions and Outlook; References; 6. Immune Properties of Mesenchymal StemCells in the Translation of Neural Disorders; Abstract; 6.1 Introduction; 6.2 MSC Immunology; 6.3 MSCs and Cancer; 6.3.1 Role in Tumor Growth; 6.3.2 MSCs in Tumor Suppression; 6.3.3 MSC and Brain Cancer; 6.4 Regenarative Potential; 6.5 Safety; 6.6 Conclusion; Refrences.